CDIO Insider Trading

Insider Ownership Percentage: 30.00%
Insider Buying (Last 12 Months): $30,455.75
Insider Selling (Last 12 Months): $0.00

Cardio Diagnostics Insider Trading History Chart

This chart shows the insider buying and selling history at Cardio Diagnostics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Cardio Diagnostics Share Price & Price History

Current Price: $0.51
Price Change: Price Decrease of -0.02 (-3.77%)
As of 07/19/2024 01:00 AM ET

This chart shows the closing price history over time for CDIO up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Cardio Diagnostics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/31/2023Meeshanthini DoganCEOBuy16,481$0.55$9,064.55128,345View SEC Filing Icon  
8/28/2023Robert PhilibertInsiderBuy18,000$0.60$10,800.001,649,792View SEC Filing Icon  
8/25/2023Meeshanthini DoganCEOBuy1,770$0.56$991.20111,864View SEC Filing Icon  
8/24/2023Robert PhilibertInsiderBuy16,000$0.60$9,600.001,631,792View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Cardio Diagnostics (NASDAQ:CDIO)

8.06% of Cardio Diagnostics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Cardio Diagnostics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
1/30/2024Vontobel Holding Ltd.12,000$30K0.0%N/A0.058%Search for SEC Filing on Google Icon
8/14/2023Prelude Capital Management LLC110,000$0.13M0.0%N/A1.134%Search for SEC Filing on Google Icon
2/14/2023Susquehanna International Group LLP23,646$26K0.0%N/A0.249%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Cardio Diagnostics logo
Cardio Diagnostics Holdings, Inc., an artificial intelligence-powered precision cardiovascular medicine company, develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment test targeting CHD events, including heart attacks; and PrecisionCHD, an integrated epigenetic-genetic blood test for the early detection of coronary heart disease. The company was founded in 2017 and is headquartered in Chicago, Illinois.
Read More on Cardio Diagnostics

Today's Range

Now: $0.51
Low: $0.51
High: $0.53

50 Day Range

MA: $0.62
Low: $0.50
High: $0.90

52 Week Range

Now: $0.51
Low: $0.17
High: $3.56

Volume

135,243 shs

Average Volume

211,889 shs

Market Capitalization

$11.57 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

4.95

Who are the company insiders with the largest holdings of Cardio Diagnostics?

Cardio Diagnostics' top insider shareholders include:
  1. Robert Philibert (Insider)
  2. Meeshanthini Dogan (CEO)
Learn More about top insider investors at Cardio Diagnostics.